Chengdi Wang

Sichuan University — China

Medicine · Health Sciences

39h-index6.2kcitations142works11.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiomics and Machine Learning in Medical Imaging(37), Lung Cancer Diagnosis and Treatment(35), Lung Cancer Treatments and Mutations(26), COVID-19 diagnosis using AI(24), Cancer-related molecular mechanisms research(22)

Publications142 total

Loss of NLN suppresses lung cancer progression by inducing ferroptosis through downregulating m6A methylation of GPX4
Redox Biology·2025· 2 citedOpen Access
AI-enabled molecular phenotyping and prognostic predictions in lung cancer through multimodal clinical information integration
Cell Reports Medicine·2025· 4 citedOpen Access
Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports
Discover Oncology·2025· 1 citedOpen Access
A microsphere loaded with chondrocyte-targeting exosomes continuously deliver miR-148a for osteoarthritis therapy
Materials Today Bio·2025· 5 citedOpen Access
China Protocol for early screening, precise diagnosis, and individualized treatment of lung cancer
Signal Transduction and Targeted Therapy·2025· 8 citedOpen Access
Risk factors associated with morbidity and unfavorable treatment outcome in drug-resistant pulmonary tuberculosis: a case-control study
Precision Clinical Medicine·2025· 1 citedOpen Access
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
Nature Communications·2025· 30 citedOpen Access
Loss of Nln Suppresses Lung Cancer Progression by Inducing Ferroptosis Through Downregulating M6a Methylation of Gpx4
SSRN Electronic Journal·2025Open Access
Data-driven risk stratification and precision management of pulmonary nodules detected on chest computed tomography
Nature Medicine·2024· 50 citedOpen Access
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
Journal of Medicinal Chemistry·2024· 31 citedOpen Access
An update on small molecule compounds targeting synthetic lethality for cancer therapy
European Journal of Medicinal Chemistry·2024· 14 cited
Single-cell RNA sequencing in tuberculosis: Application and future perspectives
Chinese Medical Journal·2024· 2 citedOpen Access
Investigating causal associations between pneumonia and lung cancer using a bidirectional mendelian randomization framework
BMC Cancer·2024· 3 citedOpen Access
A multimodal integration pipeline for accurate diagnosis, pathogen identification, and prognosis prediction of pulmonary infections
The Innovation·2024· 31 citedOpen Access
The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study
International Immunopharmacology·2024· 5 citedOpen Access
Deep learning for precise diagnosis and subtype triage of drug‐resistant tuberculosis on chest computed tomography
MedComm·2024· 19 citedOpen Access
Carnitine functions as an enhancer of NRF2 to inhibit osteoclastogenesis via regulating macrophage polarization in osteoporosis
Free Radical Biology and Medicine·2024· 12 cited
ABP: Asymmetric Bilateral Prompting for Text-Guided Medical Image Segmentation
Lecture notes in computer science·2024· 5 cited
Textmatch: Using Text Prompts to Improve Semi-supervised Medical Image Segmentation
Lecture notes in computer science·2024· 3 cited
More Early-Stage Lung Cancer Detection Via Thin-Section Low-Dose Ct Screening Combined with Artificial Intelligence in Non-High Risk Population: A Real-World Cohort Study of 264,779 Participants
SSRN Electronic Journal·2024Open Access
page 1 of 8Next →

Frequent Co-authors

Weimin Li(33), Jun Shao(18), Yizhou Yu(7), Jiechao Ma(7), Kang Zhang(6), Zhoufeng Wang(6), Jingwei Li(6), Min Zhu(5), Guangyu Wang(4), Ying Yang(4), Wenliang Qiao(4), Yong Peng(4), Xiuyuan Xu(4), Jixiang Guo(4), Yi Zhang(4), Dan Liu(4), Jun Shen(3), Zhihuan Li(3), Ye Sang(3), Xingwang Wu(3)